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Background: Diabetic polyneuropathy (DPN) is one of the most common complications of diabetes and can exist
with or without neuropathic pain. We were interested in how neuropathic pain impairs the quality of life in diabetic
patients and what is the role of comorbidities in this condition.
Methods: The study included 80 patients with painful DPN (group “P”) and 80 patients with DPN, but without
neuropathic pain (group “D”). Visual analogue scale (VAS) and Leeds assessment of neuropathic symptoms and
signs (LANSS) pain scale were used for assessment of neuropathic pain, SF-36 standardized questionnaire for
assessment of the quality of life and BDI questionnaire for assessment of depression.
Results: Subjects in group P had statistically significantly lower values compared to group D in all 8 dimensions
and both summary values of the SF-36 scale. We ascribe the extremely low results of all parameters of SF-36 scale
in group P to painful diabetic polyneuropathy with its complications. The patients in group D showed higher
average values in all dimension compared to group P, but also somewhat higher quality of life compared to general
population of Croatia in 4 of 8 dimensions, namely vitality (VT), social functioning (SF), role-emotional (RE) and
mental health (MH), which was unexpected result.
Clinically, the most pronounced differences between two groups were noted in sleeping disorders and problems
regarding micturition and defecation , which were significantly more expressed in group P. The similar situation
was with walking distance and color-doppler sonography of carotid arteries, which were significantly worse in
group P. Consequently, subjects in group P were more medicated than the patients in group D, particularly with
tramadol, antiepileptics and antidepressants.
Conclusion: Painful DPN is a major factor that influences various aspects of quality of life in diabetic patients.
Additionally, this study gives an overview of diabetic population in the Republic of Croatia, information that could
prove useful in future studies.
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Diabetes is one of the most common chronic non-
infectious diseases and one of the leading public health
problems of the modern society. It has high prevalence
and ascending trend in the number of patients in all
countries. Its late complications are the leading cause of* Correspondence: phrabac@hiim.hr
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article, unless otherwise stated.increased morbidity and mortality of the patients and
the main reason of increase of the cost of diabetes treat-
ment [1].
According to the International Diabetes Federation
(IDF), expected overall prevalence of diabetes in the year
2025 will be around 5.4%, a marked increase from 4% in
1995. Additionally, the largest number of diabetic patients,
especially in developing countries, will come from the
working population (people between 45 and 64 years of
age), while in developed countries the majority patientsoMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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classified as developed country by King [2]), according to
Croatian National Institute of Public Health (HZJZ) and
the National Diabetes Registry CroDiab, the incidence
of diabetes was 6.3% in the year 2011, with the total of
230.084 patients older than 18 years [3,4].
This tendency is reflected in the fact that diabetes is the
sixth leading cause of mortality in United States and the
seventh leading cause of mortality in Canada. The average
life span is up to 15 years shorter in diabetic patients.
Diabetes is among ten leading causes of mortality in
US [5] and Canada, significantly shortening the life span
of patients [6] and also one of the most important risk
factors in the development of cardiac and cerebrovas-
cular diseases. Additionally, complications and comor-
bidities such as myocardial infarction, stroke, foot ulcer,
amputation and blindness plague up to 50% of diabetic
patients [7]. Complications significantly decrease the qual-
ity of life, reduce estimated life span and additionally
increase the already increasing price of treatment of a dia-
betic patient [8]. This is why prevention and control of
complications in diabetic patients is one of the most
important mechanisms in any public health system.
One of the most common diabetic complications is
diabetic polyneuropathy [9,10] which can exist with or
without neuropathic pain. Its incidence is growing with
the duration of diabetes. Around 50% patients with type
II diabetes suffers from this condition, compared to ap-
proximately 30% in type I diabetes. Painful diabetic poly-
neuropathy occurs in 11-21% of patients with diabetes,
with pain being one of the most common causes for seek-
ing medical assistance. Such neuropathic pain often causes
difficulties falling asleep, sleep disturbances caused by
pain, burning sensations and itching. The loss of sleep
often leads to anxiety and depression, thus additionally
deteriorating sleeping disorders, so many patients enter a
vicious cycle of sleep deprivation. Sleep deprivation in re-
turn results in lack of energy, strongly influencing patient’s
ability to function through decreased motility and depend-
ence on others in everyday functioning [11].
Diabetic polyneuropathy, both in its painful and non-
painful form, significantly influences the patients’ quality
of life. In this context, the aims of this investigation were
to determine to what extent neuropathic pain (as one of
the manifestations of diabetic polyneuropathy) impairs the
quality of life of diabetic patients and do comorbidities
additionally worsen the quality of life in this population.
In order to gain data applicable to our daily practice,
and we believe also to practice in other similar clinics
in Croatia and EU, we decided to use a random sam-
ple of diabetic population treated in our Clinic. This ap-
proach also helps in documenting the structure of diabetic
population in Croatia in terms of age, sex, socioeconomic
status etc.Methods
This investigation included 160 patients treated in Clinical
hospital Merkur, University Clinic for Diabetes, Endo-
crinology and Metabolic Diseases “Vuk Vrhovac“ in period
from May to October 2012. Included were subjects of
both sexes, above 18 years of age, with the diagnosis of
diabetes mellitus type I or II. Subjects meeting inclusion
criteria were included consecutively, as they arrived to the
Clinic, and were divided in two cohorts, depending on the
presence or absence of neuropathic pain. The first group
of 80 subjects consisted of patients with painful dia-
betic polyneuropathy, while the other group consisted
of patients with diabetic polyneuropathy, but without
pain. Diabetic polyneuropathy was diagnosed according
to European Federation of Neurological Societies (EFNS)
guidelines for treatment of neuropathic pain [12]. Pain at
the moment of exclusion as well as within the past month
was assessed by Visual analogue scale (VAS) and Leeds
Assessment of Neuropathic Symptoms and Signs (LANSS)
pain scale. The subjects with score of 12 or more on
LANSS scale were included in the painful group, while the
subjects with the score lower than 12 were included in the
group of diabetic patients with DPN but without the
painful component [13]. The study was approved by the
authorised Ethics committee of Clinical Hospital Merkur,
with all the subjects signing informed consent for partici-
pation in the study prior to inclusion.
Detailed medical history, followed by somatic and neu-
rological status was taken from all subjects. Neurological
examination included assessment of the muscle strength
of the extremities, proprioceptive reflexes, loss of pressure
sensation (10 g Semmes Weinstein monofilament was
used to examine pressure sensation at hallux and metatar-
sal heads I, III and V) and vibration (by 128 Hz tuning
fork) on lower limbs, as well as response to non-painful
stimuli (by cotton swab), to examine the light touch sen-
sation and presence of allodynia/hyperalgesia. This also
included sonographic diagnosis of the arteries of the legs,
electomyoneurography (EMNG) of upper and lower
extremities and color-doppler flow imaging (CDFI) of
carotid arteries. While taking medical history, a special
focus was put on the existence of various comorbidities
important for this study (Table 1), as well as demographic
information (Table 2).
Several other standardized questionnaires were used to
assess quality of life, pain and mental status of the subjects.
Quality of life was assessed by SF-36 (Short Form Health
Survey) questionnaire, measuring 8 dimensions (Table 3),
which can be additionally summarized to two standardized
summary scores – PCS (Physical Component Summary)
and MCS (Mental Component Summary). All mentioned
parameters were calculated using methodology described
by Taft [14], and compared to previously known results for
the general Croatian population [15]. Aside from the two
Table 1 Comorbidity
Parameter Group P Group D P
Vision impairment
0.159
Reads with glasses 62 (82.7%) 63 (92.7%)
Reads with magnifier 8 (10.7%) 4 (5.9%)
Blind 5 (6.7%) 1 (1.5%)
Cardiac infarction 4 (5.0%) 9 (11.3%) 0.148
Angina pectoris 20 (25.0%) 13 (16.3%) 0.172
Coronary stent 3 (3.8%) 11 (13.8%) 0.025
Coronary bypass 3 (3.8%) 3 (3.8%) -
Cerebrovascular stroke 9 (11.3%) 4 (5.0%) 0.148
ACI stenosis 20 (25.0%) 10 (12.5%) 0.043
ACI operation 4 (5.0%) 3 (3.8%) 0.699
Diabetic nephropathy 8 (10.0%) 16 (20.0%) 0.076
Dialysis 5 (6.3%) 10 (12.5%) 0.175
Leg ulcer 7 (9.0%) 2 (2.6%) 0.089
Operation on legs 4 (5.1%) 4 (5.1%) 0.985
Amputation 6 (7.7%) 2 (2.6%) 0.152
Sleeping disorders 65 (81.3%) 12 (15.0%) <0.001
Micturition and defecation disorders 18 (22.5%) 4 (5.0%) 0.001
Table 2 Demographic and anamnestic data
Parameter Group P Group D P
Sex, ratio of women (%) 49 (61.3%) 28 (35.0%) <0.001
Age, years (SD) 63.7 (8.4) 61.0 (10.6) 0.077
BMI, kg/m2 (SD) 29.9 (5.7) 28.1 (4.3) 0.028
Married (%) 52 (65.0%) 61 (76.3%) 0.118
Employed, N (%)
Yes 5 (6.3%) 19 (23.8%)
0.007No 5 (6.3%) 3 (3.8%)
Retired 70 (87.5%) 58 (72.5%)
Education, N (%)
0.238
Elementary school 12 (15.0%) 6 (7.5%)
High school 48 (60.0%) 48 (60.0%)




1 14 (17.5%) 7 (8.8%)
2 36 (45.0%) 36 (45.0%)
3 11 (13.8%) 12 (15.0%)
4 and more 19 (23.8%) 25 (31.3%)
Ratio of smokers, N (%) 15 (18.8%) 15 (18.8%) -
Alcohol consumption,
N (%) 6 (7.5%) 17 (27.3%) 0.013
Daily physical activity,
hours (%)
0.092<1 46 (57.5%) 38 (47.5%)
1-2 30 (37.5%) 30 (37.5%)
2 and more 4 (5.0%) 12 (15.0%)
Financial situation
satisfaction, N (%)
<0.001Yes 9 (11.3%) 25 (31.3%)
Medium 47 (58.8%) 51 (63.8%)
No 24 (30.0%) 4 (5.0%))
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Inventory (BDI) was also used to assess the presence and
level of depressive disorder in subjects.
All data was collected by study staff (physicians and
nurses) that was blinded to the allocation of subjects to
study groups. Scales used in the study were validated
Croatian versions of scales, used in everyday clinical
practice throughout the country (LANSS and BDI). In
case of the SF-36, which is not used as extensively as the
previously mentioned scales, validated translations and
established norms previously published by Juresa [15]
and Maslic [16] were used.
The primary aim of this study was to determine the
quality of life of/in diabetic patients with painful diabetic
polyneuropathy using MCS and PCS parameters of SF-
36 scale, compared to the group of diabetic patients with
diabetic polyneuropathy, but without painful manifesta-
tions. The SF-36 scale was used deliberately, although
we are aware that there are other quality of life scales
which are specific for diabetic patients. The main advan-
tage of SF-36 is the existence of standardized values for
the general population, making the comparison pos-
sible, which would be impossible with the disease-specific
scales. The additional aim was to determine how comor-
bidity influenced the quality of life of diabetic patients.
Rather than using two patient populations comparable in
all parameters, a cross-sectional analysis based on the ran-
dom population sample was used to obtain an objective
insight into demographic, clinical and personal parameters
of the two populations.The needed number of subjects was calculated using
NCSS PASS [17] software package with the following
premises: statistical power (β) = 0.8; statistical significance
(α) = 0.05; expected difference between groups = 5 value
points of MCS or PCS parameters; expected standard de-
viation = 10 points on MCS or PCS scale. Sample size
needed was 64 subjects per group. In order to decrease
the influence of the variables unknown at the moment of
sample calculation, the sample size was increased to 80
subjects.
Statistical analysis was done in Statistica software pack-
age (StatSoft, Inc., version 10). After testing for normality
of distribution by means of Kolmogorov-Smirnov test, the
appropriate parametric and non-parametric tests were
used. For continuous variables, differences between two
groups were tested by means of either Student t-test or
Table 3 Quality of life and depression indicators
Parameter, points (SD) Group P Group D p
SF-36, PF* 28.0 (21.2) 61.9 (26.6) <0.001
SF-36, RP 13.4 (30.0) 55.9 (42.5) <0.001
SF-36, BP 30.8 (18.0) 57.0 (18.0) <0.001
SF-36, GH 28.5 (17.8) 46.8 (18.8) <0.001
SF-36, VT 39.9 (17.9) 61.0 (18.1) <0.001
SF-36, SF 53.3 (27.5) 79.8 (20.6) <0.001
SF-36, RE 43.3 (46.7) 74.2 (40.0) <0.001
SF-36, MH 52.9 (20.7) 71.9 (17.6) <0.001
SF-36, PCS 35.9 (6.2) 45.7 (8.2) <0.001
SF-36, MCS 47.8 (9.6) 55.2 (8.0) <0.001
BDI 19.1 (10.7) 9.6 (6.6) <0.001
*Dimensions and summary scores of the SF-36 scale: PF = physical functioning;
RP = role-physical; BP = bodily pain; GH = general health; VT = vitality; SF = social
functioning; RE = role-emotional; MH =mental health; PCS = physical component
summary; MCS =mental component summary.
Table 4 Basic data about the illness and lipid profile
Parameter Group P Group D P
Diabetes, type II, N (%) 75 (93.8%) 65 (81.3%) 0.017
Duration of the illness, years (SD) 16.0 (9.4) 19.0 (9.3) 0.176
Insulin, N (%) 58 (72.5%) 58 (72.5%) -
Antihypertensives, N (%) 72 (90.0%) 71 (88.8%) 0.797
Statins, N (%) 70 (87.5%) 73 (91.3%) 0.442
HbA1c, % (SD) 7.1 (1.0) 7.3 (1.1) 0.342
Cholesterol, mmol/L (SD) 4.9 (1.2) 4.8 (1.1) 0.416
HDL, mmol/L (SD) 1.4 (0.4) 1.4 (0.4) 0.917
LDL, mmol/L (SD) 2.7 (0.9) 2.6 (0.8) 0.324
Triglycerides, mmol/L (SD) 1.8 (1.3) 1.8 (1.2) 0.710
Table 5 Test results
Parameter Group P Group D p
Walking distance
0.003
<100 m 16 (20.0%) 6 (7.5%)
100-500 m 59 (73.8%) 74 (92.5%)
>500 m 5 (6.3%) 0 (0.0%)
Polyneuropathy
0.436No 0 (0.0%) 0 (0.0%)
I 11 (14.1%) 16 (20.1%)
II/III 67 (85.9%) 64 (80.0%)
EMNG
<0.001DPN 26 (32.5%) 56 (70.9%)
Radiculopathy with DPN 54 (67.5%) 23 (29.1%)
Color-doppler of arteries
0.218Stenosis or occlusion 26 (32.5%) 19 (23.8%)
Normal 54 (67.5%) 61 (76.3%)
Carotid color-doppler
0.079
Normal 1 (1.3%) 0 (0.0%)
Stenosis <50% 58 (72.5%) 69 (86.3%)
Stenosis >50% or occlusion 21 (26.3%) 11 (13.8%)
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was done by ANOVA or Kruskal-Wallis ANOVA. For cat-
egorical variables testing was done by chi-square test. The
values of categorical variables are represented as number
and proportion of subjects, while for the variables mea-
sured on interval scale means and standard deviations are
shown. The level of statistical significance was set to 0.05,
which was in case of multiple comparisons interpreted
using Bonferroni correction.
Results
One hundred and sixty subjects included in the research
were divided in two groups – diabetic patients with
painful polyneuropathy (group “P”) and diabetic patients
with polyneuropathy, but without painful sensations
(group “D”). Basic demographic and clinical history data
can be seen in Table 2., showing that two groups were
comparable considering age, marital status, education,
number of household members, smoking, BMI (after
applying Bonferroni correction for multiple analyses),
and the average time spent daily in physical activity.
Group P had significantly higher female ratio (61.3%, ver-
sus 35.0%), while the employment rate was considerably
lower (6.3%, versus 23.8%).
Regarding indicators of the primary illness, as well as
the lipid profile parameters (Table 4), the two groups
were comparable with the only exception being the type
of diabetes, with somewhat lower proportion of type II
diabetes in group D.
The type and number of comorbidities is shown in
Table 1. A higher proportion of ACI stenoses was found
in group P, while more subjects with coronary stent were
found in group D. However, the biggest (and statistically
significant) differences were found in sleeping disorders
and micturition and defecation disorders, which were bothsignificantly more expressed in group P. The similar situ-
ation was with the walking distance and the results of the
CDFI of carotid arteries, which were significantly worse in
group P (Table 5). Expectedly, the subjects in group P were
consuming more medications than the subjects in group
D, which particularly refers to tramadol and antidepres-
sants (Table 6).
Table 3 shows the parameters of the quality of life,
expressed through 8 dimensions and two summary values
of SF-36 scale. Figure 1 shows the same data, together
with the results obtained from a random sample of 5.048
people of general population of the Republic of Croatia
[15]. Besides the (expected) statistically significant differ-
ences between groups P and D in all 8 dimensions and
both summary values of SF-36 scale, it is interesting to
Table 6 Medication
Parameter Group P Group D p
NSAR 31 (38.8%) 30 (37.5%) 0.871
Tramadol 64 (80.0%) 33 (41.3%) <0.001
Antiepileptics 7 (8.8%) 1 (1.3%) 0.029
Antidepressants 50 (62.5%) 30 (37.5%) 0.002
Antispasmodics 5 (6.3%) 2 (2.5%) 0.246
Medication
<0.001
Not every day 10 (12.5%) 62 (77.5%)
1-2 a day 23 (28.8%) 17 (21.3%)
3 and more a day 47 (58.8%) 1 (1.3%)
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in 4 of 8 dimensions of the scale compared to the general
population of the Republic of Croatia. Additionally, in the
same table the mean values of BDI scale are shown, indi-
cating significantly higher level of depression in group P.
Apart from the above mentioned differences, the differ-
ences in sex were examined in the whole sample (N = 160;
83 male, 77 female). It was shown that women, although
comparable to men in terms of employment status
(p = 0.131), were on average significantly less educated
than men (p = 0.001), and were significantly less satisfied
with their financial situation (p = 0.007). These differences
were not attributable to age, since men and women were
comparable in that criterion (p = 0.298), as well as to the
type of diabetes (p = 0.256) or the presence of comorbi-
dities (p = 0.158). Additionally, men and women were
comparable in all the categories of comorbidities, except
for bypass (6 men and none of the women; p = 0.016) and
amputation (7 men, 1 woman; p = 0.037). It is also inter-
esting that men had higher quality of life, based on both
summary values of SF-36 scale, namely 43.3 versus 38.2 for
PCS (p < 0.001) and 52.8 versus 50.1 for MCS (p = 0.072).Figure 1 Mean values of the dimensions of SF-36 scale for the group
patients with painless neuropathy (grey) and random sample of popu
Role-physical (RP); Bodily pain (BP); General health (GH); Vitality (VT);Another analysis performed on the whole sample
(N = 160), was the analysis of impact of comorbidities
on the quality of life (Table 7). Of 15 comorbidities
already discussed earlier (see Table 1), five (coronary stent,
coronary bypass, ACI stenosis, leg ulcer and amputation)
had no impact on any of the dimensions and summary
scores assessed by the SF-36 scale. Presence of any of the
remaining 10 comorbidities has led to significantly lower
values in different dimensions of the SF-36 scale. Two co-
morbidities (cerebrovascular stroke and operation on legs)
impacted only one dimension. Conditions affecting numer-
ous categories were sleeping disorders, micturition and
defecation disorders, angina pectoris and blindness. Di-
mensions of the SF-36 scale affected by most comor-
bidities were physical functioning, general health and
physical component summary.
Discussion
As stated earlier, subjects were included in the study in
the order of arriving to our clinic. Since there was no
impact on the subject selection by the examiners, a cer-
tain misbalance between the groups regarding age, sex
and other parameters can be noticed (Table 2). Differ-
ence in sex is especially important because from our ex-
perience as well as from the already published results
[18], diabetic women tend to have lower level of educa-
tion compared to men of the same age and same health
status. We hypothesize that this may lead to lower in-
come and/or worse general workplace conditions for
women and consequently lower satisfaction with their fi-
nancial status as well. It is also found that men generally
have subjectively higher quality of life than women [19],
which is again confirmed in our population. One of pos-
sible explanations is that the higher level of education,
associated with greater awareness of the disease and
lifestyle choices, results in more active and effectiveof diabetic patients with painful neuropathy (black), diabetic
lation of Republic of Croatia (white) Physical functioning (PF);
Social functioning (SF); Mental Health (MH); Role-emotional (RE).
Table 7 Effect of comorbidities on the quality of life in all study subjects (N = 160)
Parameter§ BL CI AP CT CB CS AS AO DN DI LU OL AM SD MD
SF-36, PF * * ** * * ** **
SF-36, RP * ** ** **
SF-36, BP ** ** **
SF-36, GH * ** * ** * * ** **
SF-36, VT ** ** **
SF-36, SF * ** **
SF-36, RE ** **
SF-36, MH * ** **
SF-36, PCS ** * ** * * * * ** **
SF-36, MCS ** **
*§Description of SF-36 dimensions and summary scores can be found in legend for Table 6.
§BL = blind; CI = cardiac infarction; AP = angina pectoris; CT = coronary stent; CB = coronary bypass; CS = cerebrovascular stroke; AS = ACI stenosis; AO = ACI
operation; DN = diabetic nephropathy; DI = dialysis; LU = leg ulcer; OL = operation on legs; AM = amputation; SD = sleeping disorder; MD = micturition and
defecation disorders.
Legend for table cells: empty = no statistical significance; * = p<0,01; ** = p<0,001.
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concept is documented in variety of cultures and condi-
tions [22-25]. This initiates a positive feedback with more
active approach to the treatment of diabetes, better gly-
caemic control, and less serious complications. In this
context, our experience has also shown that during the
obligatory five-day education in Day hospital, where pa-
tients receive basic knowledge about diabetes and its com-
plications through a multidisciplinary approach of a
support psychologist, psychiatrist and diabetologist, pa-
tients with better education accept the facts about the dis-
ease easier and faster compared to less educated patients.
Considering our field of interest, the walking distance
was of a special concern, being one of the main indi-
cators of physical health of diabetic patients [26,27]. The
group with painful polyneuropathy expectedly had signifi-
cantly higher proportion of subjects with short walking
distance (up to 100 m). However, in the same group there
were a number of subjects (namely 5 persons) with walk-
ing distance longer than 500 m, whilst in the group of
diabetic patients without painful neuropathy there were
no such subjects. This seemingly surprising result is ex-
plicable by previously mentioned good level of disease
awareness, learned by our patients during the Day-hospital
education. Therefore, although sensing pain, patients are
taught to continue to walk to alleviate development of
collateral circulation in legs. Special clinical challenge for a
neurologist is the presence of radiculopathy in a high per-
centage of subjects in the painful group, which is also un-
expected; i.e. it was considered that diabetic patients had
reduced walking distance exclusively due to claudications
[28,29] caused by stenotic changes of the lower extremity
arteries. Our results shine a new light on the cause of this
problem, which is particularly important because therehave been no similar surveys in the diabetic population in
Croatia so far.
Bearing in mind the primary goal of this research, i.e.
the quality of life of the two groups of diabetic patients, a
significant difference between subjects with painful dia-
betic polyneuropathy and subjects without painful neur-
opathy is clearly evident. Additionally, both groups show
values significantly different from the general population.
The quality of life is expectedly lower in the painful group
than in the group of subjects with DPN without pain. We
believe that there is a number of reasons for that. Manifes-
tations of painful polyneuropathy, associated with chronic
back pain, can exhaust the patient more than the primary
illness (diabetes), and these conditions are of great im-
portance for functioning of a diabetic patient and his/her
mental status. These conditions require an additional
effort in terms of time and energy needed for treatment,
and lay a burden on subject’s financial resources in terms
of medications and additional medical treatment. These
elements, basically caused by painful symptoms, may
adversely affect the overall quality of life.
The other important factor is mental health. It reflects
on the quality of life of subjects with painful polyneurop-
athy as lower value of cumulative parameter MCS, as
well as higher level of depression according to BDI scale.
This is expected, both in terms of the higher incidence
of depression in diabetics in general [30] and in higher
intensity of depressive symptoms in group with painful
neuropathy [31]. In our opinion, and in line with some
previously published results [32,18], depression is a major
contributor impairing quality of life in diabetics.
Sleeping disorders are drastically more common in the
painful group. With its particular influence they add-
itionally deteriorate the condition of these subjects. This
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diabetic polyneuropathy is very difficult to treat, and
30-40% of patients do not respond to any kind of therapy
[33], thus increasing the overall cost of treatment [33]. In
this context, some recent studies [34] show patients more
often neglect the treatment of the primary disease, like
diabetes or hypertension, and rather take medications for
pain treatment, e.g. analgesics. This is confirmed in our
study as well, with significantly higher proportion of
subjects taking multiple medications in the painful group,
especially analgesics (Table 6). Alternatively, it is possible
that increased medication results in lower alcohol con-
sumption in the same group (Table 2).
As we have shown with the analysis of the effects of
comorbidities on the quality of life (Table 7), low values
of all SF-36 scale parameters in group P can be (in part,
at least) explained by higher prevalence of comorbidities
in the P group. This is especially true for sleeping disor-
ders and micturition/defecation disorders, both signifi-
cantly lowering all dimensions of SF-36 scale and both
significantly more prominent in P group. While negative
effects of sleep disturbances on quality of life are well
documented [35], the micturition/defecation disorders’
effects are described mostly in surgical patients. Their
consistent and statistically highly significant effect on all
dimensions of SF-36 scale is an interesting finding which
we hope will be confirmed by other researchers.
Subjects in group D have higher mean values in all
SF-36 parameters compared to group P, but also show
somewhat higher quality of life compared to general
population in Croatia in 4 of 8 dimensions, namely vitality
(VT), social functioning (SF), role-emotional (RE) and
mental health (MH), which was an unexpected result. Our
hypothesis is that this outcome was a result of a signifi-
cantly bigger portion of male subjects, as well as those
with high education in group D versus group P, but also
versus general population from year 2000 [15]. The pro-
portion of the highly educated in Croatia in year 2001 was
12.0%, and in 2011 the proportion increased to 16.4%. In
the year 2011 the proportion of the highly educated of the
age 60–64, which is the age of our subjects, was 20% for
men and 16.2% for women. The said proportions were in
a distinct opposition with subjects in group P, where
proportion of the highly educated was 25.1%, as well as in
group D where the same proportion was 32.6% [3].
Finally, quality of life of diabetic patients is one of
the most important aspects of the disease, both be-
cause of its effect on the long-term prognosis [36],
and on the economic burden of the disease [7]. Neuro-
pathic pain, besides its direct incapacitating effect on
patient, shows additional negative effect by significantly
lowering the quality of life. Treatment of neuropathic
pain can therefore have multiple positive effects on such
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